Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Human immunodeficiency virus drug resistance: 2018 recommendations of the International Antiviral Society–USA panel
Background Contemporary antiretroviral therapies (ART) and management strategies have
diminished both human immunodeficiency virus (HIV) treatment failure and the acquired …
diminished both human immunodeficiency virus (HIV) treatment failure and the acquired …
Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study
Background Antiretroviral therapy (ART) that enables suppression of HIV replication has
been successfully rolled out at large scale to HIV-positive patients in low-income and middle …
been successfully rolled out at large scale to HIV-positive patients in low-income and middle …
Persistent low-level viremia while on antiretroviral therapy is an independent risk factor for virologic failure
C Joya, SH Won, C Schofield, T Lalani… - Clinical Infectious …, 2019 - academic.oup.com
Background Whether persistent low-level viremia (pLLV) predicts virologic failure (VF) is
unclear. We used data from the US Military HIV Natural History Study (NHS), to examine the …
unclear. We used data from the US Military HIV Natural History Study (NHS), to examine the …
[HTML][HTML] Influencing factors and adverse outcomes of virologic rebound states in anti-retroviral-treated individuals with HIV infection
D Yuan, M Li, Y Zhou, L Shi, J Lu, G Fu… - Journal of Virus Eradication, 2023 - Elsevier
Antiretroviral therapy (ART) aims to inhibit HIV replication, decrease CD4 T cell loss, and
immune function recovery in order to reduce the morbidity and mortality associated with the …
immune function recovery in order to reduce the morbidity and mortality associated with the …
Drug resistance profile among HIV-1 infections experiencing ART with low-level viral load in Guangdong China during 2011–2022: a retrospective study
Y Lan, X Ling, X Deng, Y Lin, J Li, L Li… - Infection and Drug …, 2023 - Taylor & Francis
Background Antiretroviral therapy (ART) efficiently reduces the morbidities and mortalities
caused by HIV-1 infection and prevents the HIV epidemic. However, virologic failure (VF) …
caused by HIV-1 infection and prevents the HIV epidemic. However, virologic failure (VF) …
Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China
P Liu, Y You, L Liao, Y Feng, Y Shao, H **ng… - BMC infectious …, 2022 - Springer
Abstract Background Maintaining plasma HIV RNA suppression below the limit of
quantification is the goal of antiretroviral therapy (ART). When viral loads (VL) remain in low …
quantification is the goal of antiretroviral therapy (ART). When viral loads (VL) remain in low …
Effect of rifampin on the single-dose pharmacokinetics of oral cabotegravir in healthy subjects
SL Ford, K Sutton, Y Lou, Z Zhang… - Antimicrobial agents …, 2017 - journals.asm.org
Drug-drug interactions between antiretroviral medications and rifampin complicate the
treatment of HIV and tuberculosis coinfection. This study evaluated the effect of rifampin on …
treatment of HIV and tuberculosis coinfection. This study evaluated the effect of rifampin on …
The prevalence of low-level viraemia and its association with virological failure in people living with HIV: a systematic review and meta-analysis
S Zhao, W Wang, S Li, J He, W Duan… - Emerging Microbes & …, 2025 - Taylor & Francis
Low-level viraemia (LLV) following antiretroviral therapy (ART) in people living with HIV
(PLWH) has not received sufficient attention. To the determine the prevalence of LLV and its …
(PLWH) has not received sufficient attention. To the determine the prevalence of LLV and its …
[HTML][HTML] Transcriptome analysis of CD4+ T cells from HIV-infected individuals receiving ART with LLV revealed novel transcription factors regulating HIV-1 promoter …
J Chen, Y He, H Zhong, F Hu, Y Li, Y Zhang, X Zhang… - Virologica Sinica, 2023 - Elsevier
Some HIV-infected individuals receiving ART develop low-level viremia (LLV), with a plasma
viral load of 50–1000 copies/mL. Persistent low-level viremia is associated with subsequent …
viral load of 50–1000 copies/mL. Persistent low-level viremia is associated with subsequent …
Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations
Objectives To assess genotypic sensitivity scores (GSSs), plasma antiretroviral
concentrations (PACs) and immunovirological outcomes at Week 96 (W96) in patients with …
concentrations (PACs) and immunovirological outcomes at Week 96 (W96) in patients with …